93RD GENERAL ASSEMBLY
State of Illinois
2003 and 2004
HB6788

 

Introduced 02/09/04, by Sidney H. Mathias

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/312   from Ch. 56 1/2, par. 1312

    Amends the Illinois Controlled Substances Act. Provides that for the purpose of determining the number of times that a prescription for a Schedule III, IV, or V controlled substance has been refilled, a partial refill of 50% or less of the refill allowed shall be considered 50% of the refill.


LRB093 19564 RLC 45304 b

 

 

A BILL FOR

 

HB6788 LRB093 19564 RLC 45304 b

1     AN ACT concerning controlled substances.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 5. The Illinois Controlled Substances Act is
5 amended by changing Section 312 as follows:
 
6     (720 ILCS 570/312)  (from Ch. 56 1/2, par. 1312)
7     Sec. 312. Requirements for dispensing controlled
8 substances.
9     (a) A practitioner, in good faith, may dispense a Schedule
10 II controlled substance, which is a narcotic drug listed in
11 Section 206 of this Act; or which contains any quantity of
12 amphetamine or methamphetamine, their salts, optical isomers
13 or salts of optical isomers; phenmetrazine and its salts; or
14 pentazocine; and Schedule III, IV, or V controlled substances
15 to any person upon a written prescription of any prescriber,
16 dated and signed by the person prescribing on the day when
17 issued and bearing the name and address of the patient for
18 whom, or the owner of the animal for which the controlled
19 substance is dispensed, and the full name, address and registry
20 number under the laws of the United States relating to
21 controlled substances of the prescriber, if he is required by
22 those laws to be registered. If the prescription is for an
23 animal it shall state the species of animal for which it is
24 ordered. The practitioner filling the prescription shall write
25 the date of filling and his own signature on the face of the
26 written prescription. The written prescription shall be
27 retained on file by the practitioner who filled it or pharmacy
28 in which the prescription was filled for a period of 2 years,
29 so as to be readily accessible for inspection or removal by any
30 officer or employee engaged in the enforcement of this Act.
31 Whenever the practitioner's or pharmacy's copy of any
32 prescription is removed by an officer or employee engaged in

 

 

HB6788 - 2 - LRB093 19564 RLC 45304 b

1 the enforcement of this Act, for the purpose of investigation
2 or as evidence, such officer or employee shall give to the
3 practitioner or pharmacy a receipt in lieu thereof. A
4 prescription for a Schedule II controlled substance shall not
5 be filled more than 7 days after the date of issuance. A
6 written prescription for Schedule III, IV or V controlled
7 substances shall not be filled or refilled more than 6 months
8 after the date thereof or refilled more than 5 times unless
9 renewed, in writing, by the prescriber. For the purpose of
10 determining the number of times that a written prescription for
11 a Schedule III, IV, or V controlled substance has been
12 refilled, a partial refill of 50% or less of the refill allowed
13 shall count as 50% of a refill.
14     (b) In lieu of a written prescription required by this
15 Section, a pharmacist, in good faith, may dispense Schedule
16 III, IV, or V substances to any person either upon receiving a
17 facsimile of a written, signed prescription transmitted by the
18 prescriber or the prescriber's agent or upon a lawful oral
19 prescription of a prescriber which oral prescription shall be
20 reduced promptly to writing by the pharmacist and such written
21 memorandum thereof shall be dated on the day when such oral
22 prescription is received by the pharmacist and shall bear the
23 full name and address of the ultimate user for whom, or of the
24 owner of the animal for which the controlled substance is
25 dispensed, and the full name, address, and registry number
26 under the law of the United States relating to controlled
27 substances of the prescriber prescribing if he is required by
28 those laws to be so registered, and the pharmacist filling such
29 oral prescription shall write the date of filling and his own
30 signature on the face of such written memorandum thereof. The
31 facsimile copy of the prescription or written memorandum of the
32 oral prescription shall be retained on file by the proprietor
33 of the pharmacy in which it is filled for a period of not less
34 than two years, so as to be readily accessible for inspection
35 by any officer or employee engaged in the enforcement of this
36 Act in the same manner as a written prescription. The facsimile

 

 

HB6788 - 3 - LRB093 19564 RLC 45304 b

1 copy of the prescription or oral prescription and the written
2 memorandum thereof shall not be filled or refilled more than 6
3 months after the date thereof or be refilled more than 5 times,
4 unless renewed, in writing, by the prescriber. For the purpose
5 of determining the number of times that a facsimile copy of the
6 prescription or oral prescription and the written memorandum
7 thereof for a Schedule III, IV, or V controlled substance has
8 been refilled, a partial refill of 50% or less of the refill
9 allowed shall count as 50% of a refill.
10     (c) A controlled substance included in Schedule V shall not
11 be distributed or dispensed other than for a medical purpose
12 and not for the purpose of evading this Act, and then:
13         (1) only personally by a person registered to dispense
14     a Schedule V controlled substance and then only to his
15     patients, or
16         (2) only personally by a pharmacist, and then only to a
17     person over 21 years of age who has identified himself to
18     the pharmacist by means of 2 positive documents of
19     identification.
20         (3) the dispenser shall record the name and address of
21     the purchaser, the name and quantity of the product, the
22     date and time of the sale, and the dispenser's signature.
23         (4) no person shall purchase or be dispensed more than
24     120 milliliters or more than 120 grams of any Schedule V
25     substance which contains codeine, dihydrocodeine, or any
26     salts thereof, or ethylmorphine, or any salts thereof, in
27     any 96 hour period. The purchaser shall sign a form,
28     approved by the Department of Professional Regulation,
29     attesting that he has not purchased any Schedule V
30     controlled substances within the immediately preceding 96
31     hours.
32         (5) a copy of the records of sale, including all
33     information required by paragraph (3), shall be forwarded
34     to the Department of Professional Regulation at its
35     principal office by the 15th day of the following month.
36         (6) all records of purchases and sales shall be

 

 

HB6788 - 4 - LRB093 19564 RLC 45304 b

1     maintained for not less than 2 years.
2         (7) no person shall obtain or attempt to obtain within
3     any consecutive 96 hour period any Schedule V substances of
4     more than 120 milliliters or more than 120 grams containing
5     codeine, dihydrocodeine or any of its salts, or
6     ethylmorphine or any of its salts. Any person obtaining any
7     such preparations or combination of preparations in excess
8     of this limitation shall be in unlawful possession of such
9     controlled substance.
10         (8) a person qualified to dispense controlled
11     substances under this Act and registered thereunder shall
12     at no time maintain or keep in stock a quantity of Schedule
13     V controlled substances defined and listed in Section 212
14     (b) (1), (2) or (3) in excess of 4.5 liters for each
15     substance; a pharmacy shall at no time maintain or keep in
16     stock a quantity of Schedule V controlled substances as
17     defined in excess of 4.5 liters for each substance, plus
18     the additional quantity of controlled substances necessary
19     to fill the largest number of prescription orders filled by
20     that pharmacy for such controlled substances in any one
21     week in the previous year. These limitations shall not
22     apply to Schedule V controlled substances which Federal law
23     prohibits from being dispensed without a prescription.
24         (9) no person shall distribute or dispense butyl
25     nitrite for inhalation or other introduction into the human
26     body for euphoric or physical effect.
27     (d) Every practitioner shall keep a record of controlled
28 substances received by him and a record of all such controlled
29 substances administered, dispensed or professionally used by
30 him otherwise than by prescription. It shall, however, be
31 sufficient compliance with this paragraph if any practitioner
32 utilizing controlled substances listed in Schedules III, IV and
33 V shall keep a record of all those substances dispensed and
34 distributed by him other than those controlled substances which
35 are administered by the direct application of a controlled
36 substance, whether by injection, inhalation, ingestion, or any

 

 

HB6788 - 5 - LRB093 19564 RLC 45304 b

1 other means to the body of a patient or research subject. A
2 practitioner who dispenses, other than by administering, a
3 controlled substance in Schedule II, which is a narcotic drug
4 listed in Section 206 of this Act, or which contains any
5 quantity of amphetamine or methamphetamine, their salts,
6 optical isomers or salts of optical isomers, pentazocine, or
7 methaqualone shall do so only upon the issuance of a written
8 prescription blank by a prescriber.
9     (e) Whenever a manufacturer distributes a controlled
10 substance in a package prepared by him, and whenever a
11 wholesale distributor distributes a controlled substance in a
12 package prepared by him or the manufacturer, he shall securely
13 affix to each package in which that substance is contained a
14 label showing in legible English the name and address of the
15 manufacturer, the distributor and the quantity, kind and form
16 of controlled substance contained therein. No person except a
17 pharmacist and only for the purposes of filling a prescription
18 under this Act, shall alter, deface or remove any label so
19 affixed.
20     (f) Whenever a practitioner dispenses any controlled
21 substance, he shall affix to the container in which such
22 substance is sold or dispensed, a label indicating the date of
23 initial filling, the practitioner's name and address, the name
24 of the patient, the name of the prescriber, the directions for
25 use and cautionary statements, if any, contained in any
26 prescription or required by law, the proprietary name or names
27 or the established name of the controlled substance, and the
28 dosage and quantity, except as otherwise authorized by
29 regulation by the Department of Professional Regulation. No
30 person shall alter, deface or remove any label so affixed.
31     (g) A person to whom or for whose use any controlled
32 substance has been prescribed or dispensed by a practitioner,
33 or other persons authorized under this Act, and the owner of
34 any animal for which such substance has been prescribed or
35 dispensed by a veterinarian, may lawfully possess such
36 substance only in the container in which it was delivered to

 

 

HB6788 - 6 - LRB093 19564 RLC 45304 b

1 him by the person dispensing such substance.
2     (h) The responsibility for the proper prescribing or
3 dispensing of controlled substances is upon the prescriber and
4 the responsibility for the proper filling of a prescription for
5 controlled substance drugs rests with the pharmacist. An order
6 purporting to be a prescription issued to any individual, which
7 is not in the regular course of professional treatment nor part
8 of an authorized methadone maintenance program, nor in
9 legitimate and authorized research instituted by any
10 accredited hospital, educational institution, charitable
11 foundation, or federal, state or local governmental agency, and
12 which is intended to provide that individual with controlled
13 substances sufficient to maintain that individual's or any
14 other individual's physical or psychological addiction,
15 habitual or customary use, dependence, or diversion of that
16 controlled substance is not a prescription within the meaning
17 and intent of this Act; and the person issuing it, shall be
18 subject to the penalties provided for violations of the law
19 relating to controlled substances.
20     (i) A prescriber shall not preprint or cause to be
21 preprinted a prescription for any controlled substance; nor
22 shall any practitioner issue, fill or cause to be issued or
23 filled, a preprinted prescription for any controlled
24 substance.
25     (j) No person shall manufacture, dispense, deliver,
26 possess with intent to deliver, prescribe, or administer or
27 cause to be administered under his direction any anabolic
28 steroid, for any use in humans other than the treatment of
29 disease in accordance with the order of a physician licensed to
30 practice medicine in all its branches for a valid medical
31 purpose in the course of professional practice. The use of
32 anabolic steroids for the purpose of hormonal manipulation that
33 is intended to increase muscle mass, strength or weight without
34 a medical necessity to do so, or for the intended purpose of
35 improving physical appearance or performance in any form of
36 exercise, sport, or game, is not a valid medical purpose or in

 

 

HB6788 - 7 - LRB093 19564 RLC 45304 b

1 the course of professional practice.
2 (Source: P.A. 90-253, eff. 7-29-97; 91-576, eff. 4-1-00;
3 91-714, eff. 6-2-00.)